Your browser doesn't support javascript.
loading
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Ghandi, Mahmoud; Huang, Franklin W; Jané-Valbuena, Judit; Kryukov, Gregory V; Lo, Christopher C; McDonald, E Robert; Barretina, Jordi; Gelfand, Ellen T; Bielski, Craig M; Li, Haoxin; Hu, Kevin; Andreev-Drakhlin, Alexander Y; Kim, Jaegil; Hess, Julian M; Haas, Brian J; Aguet, François; Weir, Barbara A; Rothberg, Michael V; Paolella, Brenton R; Lawrence, Michael S; Akbani, Rehan; Lu, Yiling; Tiv, Hong L; Gokhale, Prafulla C; de Weck, Antoine; Mansour, Ali Amin; Oh, Coyin; Shih, Juliann; Hadi, Kevin; Rosen, Yanay; Bistline, Jonathan; Venkatesan, Kavitha; Reddy, Anupama; Sonkin, Dmitriy; Liu, Manway; Lehar, Joseph; Korn, Joshua M; Porter, Dale A; Jones, Michael D; Golji, Javad; Caponigro, Giordano; Taylor, Jordan E; Dunning, Caitlin M; Creech, Amanda L; Warren, Allison C; McFarland, James M; Zamanighomi, Mahdi; Kauffmann, Audrey; Stransky, Nicolas; Imielinski, Marcin.
Afiliación
  • Ghandi M; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Huang FW; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Jané-Valbuena J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kryukov GV; University of California San Francisco, San Francisco, CA, USA.
  • Lo CC; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • McDonald ER; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Barretina J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Gelfand ET; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Bielski CM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Li H; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Hu K; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Andreev-Drakhlin AY; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Kim J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Hess JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Haas BJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Aguet F; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Weir BA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Rothberg MV; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Paolella BR; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Lawrence MS; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Akbani R; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Lu Y; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Tiv HL; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Gokhale PC; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • de Weck A; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Mansour AA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Oh C; Harvard Medical School, Boston, MA, USA.
  • Shih J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hadi K; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rosen Y; Belfer Center for Applied Cancer Science, Boston, MA, USA.
  • Bistline J; Belfer Center for Applied Cancer Science, Boston, MA, USA.
  • Venkatesan K; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Reddy A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Sonkin D; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Liu M; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Lehar J; New York Genome Center, New York, NY, USA.
  • Korn JM; Department of Pathology and Laboratory Medicine, Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Porter DA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Jones MD; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Golji J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Caponigro G; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Taylor JE; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Dunning CM; National Cancer Institute, Rockville, MD, USA.
  • Creech AL; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Warren AC; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • McFarland JM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Zamanighomi M; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Kauffmann A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Stransky N; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Imielinski M; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Nature ; 569(7757): 503-508, 2019 05.
Article en En | MEDLINE | ID: mdl-31068700
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Línea Celular Tumoral / Neoplasias Límite: Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Línea Celular Tumoral / Neoplasias Límite: Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos